EULAV Asset Management - MEDIVATION INC ownership

Quarter-by-quarter ownership
EULAV Asset Management ownership history of MEDIVATION INC
ValueSharesWeighting
Q2 2016$21,406,000
+43.3%
355,000
+9.2%
1.18%
+40.9%
Q1 2016$14,943,000
+5.5%
325,000
+10.9%
0.83%
+7.6%
Q4 2015$14,164,000
+25.3%
293,000
+10.2%
0.78%
+20.5%
Q3 2015$11,305,000
+6.4%
266,000
+186.0%
0.64%
+15.4%
Q2 2015$10,621,000
-16.0%
93,000
-5.1%
0.56%
-14.6%
Q1 2015$12,649,000
+23.3%
98,000
-4.9%
0.65%
+18.1%
Q4 2014$10,260,000
+5.9%
103,000
+5.1%
0.55%
+4.7%
Q3 2014$9,689,000
+947.5%
98,000
+716.7%
0.53%
+954.0%
Q2 2014$925,00012,0000.05%
Other shareholders
MEDIVATION INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,484,101$148,897,00079.45%
BB BIOTECH AG 1,449,706$86,895,0004.73%
SECTORAL ASSET MANAGEMENT INC 1,013,529$60,751,0002.92%
Orbimed Advisors 2,284,500$136,933,0002.44%
Archipel Asset Management AB 191,016$11,449,0002.35%
BENNETT LAWRENCE MANAGEMENT L L C/NY 147,060$8,815,0001.43%
KINGDON CAPITAL MANAGEMENT, L.L.C. 450,000$26,973,0001.32%
QVT Financial LP 305,128$18,289,0001.24%
Bain Capital Public Equity Management, LLC 825,687$49,492,0001.24%
Tradeworx Inc. 44,484$2,666,0001.22%
View complete list of MEDIVATION INC shareholders